< 生产厂家价格 >

2-甲酰基噻唑

2-甲酰基噻唑用途

【用途一】
用作医药中间体

点击显示

2-甲酰基噻唑名称

[ CAS 号 ]:
10200-59-6

[ 中文名 ]:
2-醛基噻唑

[ 英文名 ]:
2-Thiazolecarboxaldehyde

[中文别名 ]:

2-甲酰基噻唑

[英文别名 ]:

2-Thiazolecarboxaldehyde
MFCD00142924
Thiazole-2-carbaldehyde
1,3-Thiazole-2-carbaldehyde
2-Formylthiazole

2-甲酰基噻唑物理化学性质

[ 密度 ]:
1.4±0.1 g/cm3

[ 沸点 ]:
218.3±23.0 °C at 760 mmHg

[ 分子式 ]:
C₄H₃NOS

[ 分子量 ]:
113.138

[ 闪点 ]:
85.8±22.6 °C

[ 精确质量 ]:
112.993530

[ PSA ]:
58.20000

[ LogP ]:
0.50

[ 外观性状 ]:
黄色液体

[ 蒸汽压 ]:
0.2±0.4 mmHg at 25°C

[ 折射率 ]:
1.621

[ 储存条件 ]:
Refrigerator (+4°C)

[ 水溶解性 ]:
soluble

2-甲酰基噻唑MSDS

2-甲酰基噻唑安全信息

[ 危害码 (欧洲) ]:
Xn:Harmful;

[ 风险声明 (欧洲) ]:
R22;R36/37/38

[ 安全声明 (欧洲) ]:
S36/37/39-S26-S23

[ WGK德国 ]:
3

[ 海关编码 ]:
2934100090

2-甲酰基噻唑合成路线

2-甲酰基噻唑上下游产品

2-甲酰基噻唑上游产品

2-甲酰基噻唑下游产品

2-甲酰基噻唑海关

[ 海关编码 ]: 2934100090

[ 中文概述 ]:
2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

2-甲酰基噻唑文献

Design, synthesis, antinociceptive and anti-inflammatory activities of novel piroxicam analogues.

Molecules 17(12) , 14126-45, (2012)

In this paper we report the design, synthesis, antinociceptive and anti-inflammatory activities of a series of benzothiazine N-acylhydrazones 14a–h, planned by structural modification of piroxicam (1)...

Asymmetric synthesis of an N-acylpyrrolidine for inhibition of HCV polymerase.

J. Org. Chem. 73(8) , 3094-102, (2008)

A practical asymmetric synthesis of a highly substituted N-acylpyrrolidine on multi-kilogram scale is described. The key step in the construction of the three stereocenters is a [3+2] cycloaddition of...

New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals. Part 5.

Bioorg. Med. Chem. Lett. 14(12) , 3209-3215, (2004)

To improve the metabolic stability of 3, which exhibited both in vitro antitumor activity and in vivo efficacy by both iv and po administration, we designed and synthesized new taxane analogues. Most ...

更多文献